Article Versions Notes

Czopek A, Koczurkiewicz-Adamczyk P, Wójcik-Pszczoła K, Kornas D, Sitko W, Bucki A, Sapa M, Kamiński K, Satała G, Duszyńska B, et al. Novel Dual 5-HT₇ Antagonists and Sodium Channel Inhibitors as Potential Therapeutic Agents with Antidepressant and Anxiolytic Activities. Pharmaceuticals. 2025; 18(10):1485. https://doi.org/10.3390/ph18101485

Czopek, Anna, Paulina Koczurkiewicz-Adamczyk, Katarzyna Wójcik-Pszczoła, Daria Kornas, Wojciech Sitko, Adam Bucki, Michał Sapa, Krzysztof Kamiński, Grzegorz Satała, Beata Duszyńska, and et al. 2025. "Novel Dual 5-HT₇ Antagonists and Sodium Channel Inhibitors as Potential Therapeutic Agents with Antidepressant and Anxiolytic Activities" Pharmaceuticals 18, no. 10: 1485. https://doi.org/10.3390/ph18101485

Czopek, A., Koczurkiewicz-Adamczyk, P., Wójcik-Pszczoła, K., Kornas, D., Sitko, W., Bucki, A., Sapa, M., Kamiński, K., Satała, G., Duszyńska, B., Bojarski, A. J., Latacz, G., Czopek, J., Szpor, J., Dryja, P., & Sałat, K. (2025). Novel Dual 5-HT₇ Antagonists and Sodium Channel Inhibitors as Potential Therapeutic Agents with Antidepressant and Anxiolytic Activities. Pharmaceuticals, 18(10), 1485. https://doi.org/10.3390/ph18101485